Liu Tongtong, Guan Yingjie, Li Juan, Mao Huimin, Zhan Yongli
Guang'anmen Hospital, China Academy of Chinese Medical Sciences.
Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Medicine (Baltimore). 2020 Nov 20;99(47):e23218. doi: 10.1097/MD.0000000000023218.
Cardiovascular disease is the main cause of death in patients with chronic kidney disease (CKD). Studies have found that hypothyroidism can significantly increase cardiovascular risk. Meanwhile, hypothyroidism is a common complication of CKD, but the correlation between hypothyroidism and cardiovascular risk in CKD patients has not been verified and paid enough attention. We therefore plan to conduct a systematic review and meta-analysis to explore whether hypothyroidism was independently predictive for the cardiovascular risk in patients with CKD.
We will search in PubMed, Embase Database, Web of Science, China National Knowledge Infrastructure (CNKI), China Biology Medicine Database (CBM), and Wanfang Database, and include the cross-sectional studies, case--control studies, and cohort studies that explore the association between hypothyroidism and cardiovascular risk in CKD patients. According to the eligibility criteria, two researchers will independently screen the retrieved literature, evaluate the methodological quality, and extract data. We will combine the extracted data based on STATA and TSA software.
This systematic review will assess the association between hypothyroidism and cardiovascular risk in CKD patients based on the incidence of cardiovascular events in CKD people with hypothyroidism.
This study will provide more evidence for the correlation between hypothyroidism and cardiovascular risk in CKD patients, which will contribute to the management and clinical practice of CKD population.
This protocol is based on available literatures so that the ethical approval and informed consent are not applicable. The results of this study will be published in a peer-reviewed journals or relevant conferences.
INPLASY2020100022.
心血管疾病是慢性肾脏病(CKD)患者的主要死因。研究发现,甲状腺功能减退症可显著增加心血管疾病风险。同时,甲状腺功能减退症是CKD的常见并发症,但甲状腺功能减退症与CKD患者心血管疾病风险之间的相关性尚未得到验证,也未得到足够重视。因此,我们计划进行一项系统评价和荟萃分析,以探讨甲状腺功能减退症是否是CKD患者心血管疾病风险的独立预测因素。
我们将检索PubMed、Embase数据库、科学引文索引、中国知网、中国生物医学文献数据库和万方数据库,并纳入探索CKD患者甲状腺功能减退症与心血管疾病风险之间关联的横断面研究、病例对照研究和队列研究。根据纳入标准,两名研究人员将独立筛选检索到的文献,评估方法学质量,并提取数据。我们将基于STATA和TSA软件合并提取的数据。
本系统评价将根据甲状腺功能减退的CKD患者中心血管事件的发生率,评估甲状腺功能减退症与CKD患者心血管疾病风险之间的关联。
本研究将为甲状腺功能减退症与CKD患者心血管疾病风险之间的相关性提供更多证据,这将有助于CKD人群的管理和临床实践。
本方案基于现有文献,因此无需伦理批准和知情同意。本研究结果将发表在同行评审期刊或相关会议上。
INPLASY2020100022。